Search Result "Raltegravir."
Diketoacid Inhibitors of HIV-1 Integrase: From L-708,906 to Raltegravir and Beyond
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 8 Year: 2012 Page: 1177-1192
Author(s): K. D. Beare, M. J. Coster, P. J. Rutledge
Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics
Journal: Current HIV Research
Volume: 14 Issue: 1 Year: 2016 Page: 54-60
Author(s): Andrea Calcagno,Chiara Montrucchio,Amedeo Capetti,G. Guaraldi,G. Cenderello,Leonardo Calza,M. Lanzafame,Letizia Marinaro,M.C. Tettoni,Laura Trentini,Aantonio D'Avolio,Giovanni Di Perri,Stefano Bonora
Neutral Actions of Raltegravir on Adipogenesis, Glucose Metabolism and Lipolysis in 3T3-L1 Adipocytes
Journal: Current HIV Research
Volume: 9 Issue: 3 Year: 2011 Page: 174-179
Author(s): Patricia Perez-Matute, Laura Perez-Martinez, Jose R. Blanco, Jose A. Oteo
Long-Term Treatment With Raltegravir is Associated with Lower Triglycerides and Platelets Count in the Older HIV+ Population: Results from the Ral-Age Study
Journal: Current HIV Research
Volume: 15 Issue: 5 Year: 2017 Page: 355-360
Author(s):
Long-Term Safety from the Raltegravir Clinical Development Program
Journal: Current HIV Research
Volume: 9 Issue: 1 Year: 2011 Page: 40-53
Author(s): Hedy Teppler, Deborah D. Brown, Randi Y. Leavitt, Peter Sklar, Hong Wan, Xia Xu, Fabio Lievano, Heidi P. Lehman, T. Christopher Mast, Bach-Yen T. Nguyen
Switching to Raltegravir in Virologically Suppressed in HIV-1-Infected Patients: A Retrospective, Multicenter, Descriptive Study
Journal: Current HIV Research
Volume: 10 Issue: 8 Year: 2012 Page: 673-678
Author(s): Daniel Podzamczer,Esteban Martinez,Pere Domingo,Elena Ferrer,Pompeyo Viciana,Jordi Curto,Maria-Jesus Perez-Elias,Antonio Ocampo,Ignacio Santos,Hernando Knobel,Vicente Estrada,Eugenia Negredo,Ferran Segura,Joaquin Portilla,Esteban Ribera,Josefa Galindo,Antonio Antela,Jorge Carmena,Manuel Castano,The TORAL Study Group
Anti-HIV Integrase Inhibitors as New Candidates for the Treatment ofCOVID-19: A Narrative Literature Review
Journal: Anti-Infective Agents
Volume: 20 Issue: 2 Year: 2022 Page: 59-64
Author(s): Sofia Salari,Hedyieh Karbasforooshan,Hesamoddin Hosseinjani
The Use of Nucleoside Reverse Transcriptase Inhibitors Sparing Regimens in Treatment-Experienced HIV-1 Infected Patients
Journal: Current HIV Research
Volume: 11 Issue: 3 Year: 2013 Page: 179-186
Author(s): Antonio Di Biagio,Elena Ricci,Claudio Viscoli,Alessio Mesini,Barbara Menzaghi,Laura Carenzi,Giancarlo Orofino,Giustino Parruti,Canio Martinelli,Giordano Madeddu,Giuseppe Vittorio De Socio,Marco Franzetti,Tiziana Quirino,Paolo Paolo Bonfanti on behalf of the CISAI Group
HIV-1 IN Inhibitors: 2010 Update and Perspectives
Journal: Current Topics in Medicinal Chemistry
Volume: 9 Issue: 1 Year: 2009 Page: 1016-1037
Author(s): Christophe Marchand, Kasthuraiah Maddali, Mathieu Metifiot, Yves Pommier
HIV-1 Integrase Inhibitors to Treat AIDS
Ebook: Frontiers in Clinical Drug Research: HIV
Volume: 2 Year: 2015
Author(s): Shengxi Chen
Doi: 10.2174/9781681082011115020006